Esperion Therapeutics Inc. (ESPR): The stock ticks all the boxes for top investors – Invest Chronicle

Esperion Therapeutics Inc. (ESPR): The stock ticks all the boxes for top investors

Esperion Therapeutics Inc. (ESPR) is priced at $10.02 after the most recent trading session. At the very opening of the session, the stock price was $7.16 and reached a high price of $10.02, prior to closing the session it reached the value of $7.12. The stock touched a low price of $7.0167.Recently in News on November 12, 2021, Esperion Presents Important New Science Highlighting Potential Benefits of NEXLETOL® (bempedoic acid) Tablets at American Heart Association Scientific Sessions 2021. – Analysis of pooled Phase 3 data showed that NEXLETOL [bempedoic acid (BA)] alone lowered LDL-C levels comparable to that of a moderate- or high-intensity statin (≥ 30%) in nearly 1 out of 3 of patients -. You can read further details here

Esperion Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $39.49 on 01/27/21, with the lowest value was $6.97 for the same time period, recorded on 11/22/21.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Esperion Therapeutics Inc. (ESPR) full year performance was -63.35%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Esperion Therapeutics Inc. shares are logging -74.63% during the 52-week period from high price, and 43.76% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $6.97 and $39.49.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4942936 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Esperion Therapeutics Inc. (ESPR) recorded performance in the market was -61.46%, having the revenues showcasing -26.59% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 301.10M, as it employees total of 479 workers.

The Analysts eye on Esperion Therapeutics Inc. (ESPR)

During the last month, 0 analysts gave the Esperion Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 12.48, with a change in the price was noted -10.47. In a similar fashion, Esperion Therapeutics Inc. posted a movement of -51.10% for the period of last 100 days, recording 939,024 in trading volumes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Technical rundown of Esperion Therapeutics Inc. (ESPR)

Raw Stochastic average of Esperion Therapeutics Inc. in the period of last 50 days is set at 49.43%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 79.02%. In the last 20 days, the company’s Stochastic %K was 29.30% and its Stochastic %D was recorded 14.47%.

Considering, the past performance of Esperion Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -61.46%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -49.82%, alongside a downfall of -63.35% for the period of the last 12 months. The shares increased approximately by 17.74% in the 7-day charts and went down by 28.63% in the period of the last 30 days. Common stock shares were lifted by -26.59% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam